Dr. Terese Hammond
Head of Development
Replay available
MiNK Therapeutics, Inc. (INKT) Q3 2025 Earnings Call
MiNK Therapeutics, Inc. (NASDAQ: INKT) Q3 2025 earnings conference call, held 2025-11-14. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Emily Bodnar
Analyst, HC Wainwright
Christine Klaskin
Principal Financial and Accounting Officer
Stephanie Perna-Nakar
Chief Communication Officer
Dr. Jennifer Buell
President and Chief Executive Officer
Mayank Mumtani
Analyst, B. Riley
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Mink Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.258 Good morning and welcome to Mink Therapeutics' third quarter 2025 conference call 00:00:05.258 -- 00:00:10.264 and webcast. All participants will be in a listen-only mode until the question and 00:00:10.264 -- 00:00:12.087 answer session. 00:00:12.087 -- 00:00:17.113 Please note this event is being recorded. If anyone has any objections, you 00:00:17.113 -- 00:00:22.060 may disconnect at this time. I would now like to turn the conference over to Stephanie 00:00:22.060 -- 00:00:28.426 Perna-Nakar, Chief Communication Officer. Stephanie, please go ahead. 00:00:28.735 -- 00:00:31.739 Thank you, Operator, and thank you all for joining us today. 00:00:31.739 -- 00:00:37.987 Today's call is being webcast and will be available on our website for replay. 00:00:37.987 -- 00:00:42.213 I'd like to remind you that this call will include forward-looking statements, including 00:00:42.213 -- 00:00:47.380 those related to our clinical development, regulatory and commercial plans, 00:00:47.380 -- 00:00:51.586 timelines for data releases, and partnership opportunities. 00:00:51.586 -- 00:00:55.150 These statements are subject to risks and uncertainties. 00:00:55.150 -- 00:01:00.247 Please refer to our SEC filings available on our website for a detailed description 00:01:00.247 -- 00:01:05.435 of these risks. Joining me today are Dr. Jennifer Buell, President 00:01:05.435 -- 00:01:10.964 and Chief Executive Officer, Dr. Terese Hammond, Head of Development, 00:01:10.964 -- 00:01:14.870 and Christine Klaskin, Principal Financial and Accounting Officer. 00:01:14.870 -- 00:01:21.337 I'd like to turn the call over to Dr. Buell to highlight our progress from this quarter. 00:01:22.803 -- 00:01:24.065 Thank you, Stephanie. 00:01:24.065 -- 00:01:29.991 Good...